Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Post by MetzGERon Jul 02, 2024 3:33pm
177 Views
Post# 36115011

CONTACT BCSC FOR LIFTING TRADING BAN !!

CONTACT BCSC FOR LIFTING TRADING BAN !!

After a phone call with CIRO they told me to contact the BCSC because the BCSC is the Institution to decide whether the trading ban will be lifted.

Please all contact BCSC (British Columbia Securities Commission)

Report to the BCSC that the trading halt of Replicel Must be canceled immediately. After RepliCels hair regeneration technology was commercialized of Shiseido Company Replicel is a very valuable Company Holding worldwide rights of this Technology in Europe, America, South America, many Asian Countries.. 
Replicel has to be back on the Stock market
immediately. Furthermore we dont want a Voting After which Mr Schutte expropriate us and takes 92% of The Companys assets. It is our job to prevent this with all our might. We only have a few days left for this - thank you all!
 

BCSC Complaints or Concerns 

If you have a complaint or concern about an individual or issuer in British Columbia, and you believe it is within the BCSC's jurisdiction you can file a complaint online. Learn more about ourcomplaint process and accessing our complaint form. 

For more information contact theBCSC Contact Centre Telephone: 

604-899-6854 or 1-800-373-6393 (toll free across Canada) 
Email:inquiries@bcsc.bc.ca

 

<< Previous
Bullboard Posts
Next >>